FZD5 — Frizzled Class Receptor 5
Introduction
FZD5 (Frizzled Class Receptor 5) encodes a seven-transmembrane receptor that serves as a key Wnt ligand receptor in the central nervous system. FZD5 is one of the most widely expressed Frizzled receptors in the brain and plays critical roles in neural development, synaptic plasticity, and neuronal survival[@daniele2014]. Given the well-established involvement of Wnt signaling dysregulation in Alzheimer's disease (AD), FZD5 has emerged as a gene of significant interest in neurodegeneration research.
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">FZD5</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>FZD5</td></tr>
<tr><td><strong>Full Name</strong></td><td>Frizzled Class Receptor 5</td></tr>
<tr><td><strong>Chromosome</strong></td><td>2q33.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/7852">7852</a></td></tr>
<tr><td><strong>OMIM</strong></td><td>602453</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000163235</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9ULW1">Q9ULW1</a></td></tr>
<tr><td><strong>Protein Name</strong></td><td>Frizzled-5</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Retinal Degeneration, Cancer</td></tr>
</table>
</div>
Overview
...
FZD5 — Frizzled Class Receptor 5
Introduction
FZD5 (Frizzled Class Receptor 5) encodes a seven-transmembrane receptor that serves as a key Wnt ligand receptor in the central nervous system. FZD5 is one of the most widely expressed Frizzled receptors in the brain and plays critical roles in neural development, synaptic plasticity, and neuronal survival[@daniele2014]. Given the well-established involvement of Wnt signaling dysregulation in Alzheimer's disease (AD), FZD5 has emerged as a gene of significant interest in neurodegeneration research.
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">FZD5</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>FZD5</td></tr>
<tr><td><strong>Full Name</strong></td><td>Frizzled Class Receptor 5</td></tr>
<tr><td><strong>Chromosome</strong></td><td>2q33.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/7852">7852</a></td></tr>
<tr><td><strong>OMIM</strong></td><td>602453</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000163235</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9ULW1">Q9ULW1</a></td></tr>
<tr><td><strong>Protein Name</strong></td><td>Frizzled-5</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Retinal Degeneration, Cancer</td></tr>
</table>
</div>
Overview
FZD5 is a member of the Frizzled family of Wnt receptors, characterized by a seven-transmembrane domain structure resembling G-protein-coupled receptors. Unlike canonical Frizzled receptors that primarily signal through β-catenin, FZD5 can activate both canonical and non-canonical Wnt pathways depending on the cellular context and available ligands[@vassilieva2003].
In the nervous system, FZD5 is critically involved in:
- Neural tube patterning and brain development
- Neuronal polarization and axon guidance
- Synapse formation and plasticity
- Neuroprotection against toxic insults
The connection between FZD5 and Alzheimer's disease stems from the broader role of Wnt signaling in maintaining neuronal health. Wnt pathway dysregulation is consistently observed in AD brains, and restoring Wnt signaling has shown neuroprotective effects in preclinical models[@inestrosa2012].
Molecular Function
Wnt Signal Transduction
FZD5 functions as a receptor for multiple Wnt ligands, with particular affinity for Wnt1, Wnt2, Wnt3, Wnt3A, and Wnt5A. Upon ligand binding, FZD5 activates downstream signaling cascades[@chen2021]:
Canonical Wnt/β-catenin pathway:
- Activation of Dishevelled (DVL) proteins
- Inhibition of glycogen synthase kinase-3β (GSK-3β)
- Stabilization of β-catenin
- Transcriptional activation of target genes
Non-canonical pathways:
- Wnt5a/Fzd5 activates planar cell polarity (PCP) signaling
- Modulates calcium signaling
- Regulates cytoskeletal dynamics
Neuroprotective Signaling
FZD5-mediated neuroprotection involves several mechanisms[@liu2018]:
Anti-apoptotic signaling: Wnt/Fzd5 activation upregulates anti-apoptotic proteins including Bcl-2
Synaptic protection: Maintains synaptic protein expression and function
Anti-oxidant effects: Reduces oxidative stress in neurons
Aβ clearance: Promotes amyloid-beta clearance mechanismsRole in Alzheimer's Disease
Wnt Signaling Dysregulation
Multiple studies have documented reduced Wnt signaling in Alzheimer's disease brains. FZD5 expression is altered in AD, contributing to the overall decline in neuroprotective Wnt signaling[@inestrosa2012]:
- Reduced FZD5 mRNA and protein in AD prefrontal cortex
- Decreased Wnt ligand availability in the AD brain microenvironment
- Impaired downstream signaling despite receptor availability
Amyloid-Beta Toxicity
FZD5 activation provides protection against amyloid-beta (Aβ) toxicity, a central pathological feature of AD. The mechanisms include[@palomer2013]:
- Prevention of Aβ-induced synaptic loss
- Reduction of tau hyperphosphorylation
- Maintenance of neuronal calcium homeostasis
- Protection against mitochondrial dysfunction
Therapeutic Potential
FZD5 represents a potential therapeutic target for AD through several approaches[@martinez2019]:
- FZD5 agonists: Small molecules or peptides that activate FZD5
- Wnt pathway modulators: Compounds that enhance overall Wnt signaling
- Gene therapy: Delivery of FZD5 or Wnt ligands to the brain
Expression Pattern
Brain Expression
FZD5 is widely expressed throughout the human brain[@martinez2019]:
- Cortex: All layers, particularly layer II pyramidal neurons
- Hippocampus: CA1-CA3 pyramidal cells, dentate gyrus granule cells
- Cerebellum: Purkinje cells and granule cells
- Basal ganglia: Striatal medium spiny neurons
- Brainstem: Various nuclear regions
Development Expression
During brain development, FZD5 expression is highest in:
- Neural tube ventricular zone
- Cortical plate during corticogenesis
- Developing retina
- Migrating neurons
Disease Associations
| Disease | Association | Mechanism |
|---------|-------------|-----------|
| Alzheimer's Disease | Risk/Modifier | Wnt dysregulation, neuroprotection loss |
| Retinal Degeneration | Risk | Essential for retinal vascularization |
| Colorectal Cancer | Oncogenic | Wnt pathway activation |
| Glioma | Oncogenic | Enhanced proliferation |
Retinal Function
FZD5 is essential for proper retinal development and maintenance[@werk2018]:
- Controls retinal angiogenesis during development
- Regulates cone photoreceptor development
- Maintains retinal pigment epithelium
- Protects against age-related macular degeneration
The dual role of FZD5 in both brain and retinal health makes it relevant for understanding shared neurodegenerative mechanisms.
Interactions
FZD5 interacts with several proteins[@liu2022]:
- WNT1, WNT2, WNT3, WNT3A, Wnt5A: Primary ligands
- LRP5, LRP6: Co-receptors for canonical signaling
- DVL1, DVL2, DVL3: Intracellular signaling effectors
- RSPO1, RSPO2, RSPO3: R-spondins (potentiators)
- GSK-3β: Key downstream kinase
- β-catenin: Transcriptional co-activator
Therapeutic Targeting
Several strategies are being explored to target FZD5 in disease[@ueno2020]:
- FZD5 agonists: Activate the receptor directly
- Wnt pathway activators: Increase overall pathway activity
- Monoclonal antibodies: Target FZD5 for specific applications
Preclinical studies have shown that FZD5 activation can improve cognitive function in animal models of AD, though translation to human therapeutics remains an active area of research.
See Also
- [Wnt Signaling Pathway](/mechanisms/wnt-signaling-neurodegeneration) — Wnt pathway overview
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Alzheimer's disease overview
- [FZD4 Gene](/genes/fzd4) — Related Frizzled receptor
- [GSK-3β](/proteins/gsk3-beta) — Key downstream kinase
- [Beta-catenin](/proteins/beta-catenin) — Wnt pathway effector
- [Amyloid-beta](/proteins/amyloid-beta) — AD pathological protein
External Links
- [NCBI Gene: FZD5](https://www.ncbi.nlm.nih.gov/gene/7852)
- [OMIM: FZD5](https://www.omim.org/entry/602453)
- [Ensembl: FZD5](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163235)
- [UniProt: FZD5](https://www.uniprot.org/uniprot/Q9ULW1)
- [GeneCards: FZD5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD5)
References
[Daniele et al., Frizzled5 controls neuronal polarization (2014)](https://pubmed.ncbi.nlm.nih.gov/24715455/)
[Vassilieva et al., Wnt5a and Frizzled5 in hippocampus (2003)](https://pubmed.ncbi.nlm.nih.gov/12941731/)
[Chen et al., Wnt5a/Fzd5 in neuronal survival (2021)](https://pubmed.ncbi.nlm.nih.gov/33479175/)
[Liu et al., Frizzled receptors in AD (2018)](https://pubmed.ncbi.nlm.nih.gov/29562571/)
[Werk et al., Fzd5 deletion and retinal degeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/30550372/)
[Liu et al., Frizzled5 in retinal development (2022)](https://pubmed.ncbi.nlm.nih.gov/34861142/)
[Ueno et al., Frizzled5 in cancer (2020)](https://pubmed.ncbi.nlm.nih.gov/33028440/)
[Inestrosa et al., Wnt signaling in AD (2012)](https://pubmed.ncbi.nlm.nih.gov/22343176/)
[Palomer et al., Wnt pathway neuroprotection (2013)](https://pubmed.ncbi.nlm.nih.gov/23186628/)
[Martinez et al., Frizzled receptors in human brain (2019)](https://pubmed.ncbi.nlm.nih.gov/30739789/)